Cardiovascular & hematological disorders drug targets
Lipoprotein(a) Lowering with Pelacarsen (TQJ230).
Kunal Sharma, Lakshmi Kattamuri, Debabrata Mukherjee
Published: 202510.2174/011871529X399029250923100015
Abstract
BACKGROUND: Elevated levels of lipoprotein(a) have been linked to an increased risk of Atherosclerotic Cardiovascular Disease (ASCVD). Conventional lipid-lowering medications have modest to no impact on Lp(a) levels. Emerging RNA-based modalities sig…
Preview only. Read the full abstract at the source